PFM
MRNA icon

Privium Fund Management’s Moderna MRNA Stock Holding History

Privium Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Hold
29,994
– – 0.39% 37
2026
Q1 		$1.52M Sell
29,994
-19,600
-40% -$914K 0.32% 39
2025
Q4 		$1.46M Buy
49,594
+2,594
+6% +$70.5K 0.27% 38
2025
Q3 		$1.21M Sell
47,000
-56,433
-55% -$1.57M 0.22% 40
2025
Q2 		$2.97M Buy
103,433
+27,857
+37% +$734K 0.64% 20
2025
Q1 		$2.14M Sell
75,576
-6,900
-8% -$245K 0.56% 23
2024
Q4 		$3.43M Buy
82,476
+41,994
+104% +$2.01M 0.78% 23
2024
Q3 		$2.71M Buy
40,482
+17,221
+74% +$1.58M 0.67% 28
2024
Q2 		$2.72M Sell
23,261
-16,600
-42% -$2.1M 0.69% 29
2024
Q1 		$4.25M Sell
39,861
-4,000
-9% -$403K 1.13% 25
2023
Q4 		$4.93M Hold
43,861
– – 1.37% 23
2023
Q3 		$4.53M Buy
43,861
+13,310
+44% +$1.48M 1.35% 23
2023
Q2 		$3.73M Buy
30,551
+10,000
+49% +$1.33M 1.07% 25
2023
Q1 		$3.16M Buy
20,551
+1,500
+8% +$247K 1.06% 25
2022
Q4 		$3.41M Sell
19,051
-2,400
-11% -$392K 1.29% 25
2022
Q3 		$2.53M Buy
21,451
+751
+4% +$114K 0.92% 32
2022
Q2 		$2.96M Buy
20,700
+15,700
+314% +$2.24M 0.98% 28
2022
Q1 		$861K Buy
+5,000
New +$842K 0.19% 67

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Privium Fund Management's MRNA Position: Q2 2026 in Review

Privium Fund Management held its Moderna (MRNA) position steady in Q2 2026 at 29,994 shares worth $2.1M. The position accounts for 0.39% of the portfolio, ranked #37.

Privium Fund Management first reported a position in MRNA in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.93M in Q4 2023. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Privium Fund Management held 29,994 shares of Moderna worth $2.1M as of Q2 2026.
  • Privium Fund Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.39% of Privium Fund Management's portfolio in Q2 2026, its #37 holding.
  • Privium Fund Management first reported a position in Moderna in Q1 2022 and has held it in 18 quarters since.
  • Privium Fund Management's Moderna position peaked at $4.93M in Q4 2023.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Privium Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.